Chemoinformaics analysis of 1,1,2-TRIMETHYL-1,2-DIHYDRONAPHTHALENE
| Molecular Weight | 172.271 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 11 |
| Exact Molecular Weight | 172.125 | nRing | 2 |
| Solubility: LogS | -4.859 | nHRing | 0 |
| Solubility: LogP | 4.452 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 32.3787 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.56 |
| Synth | 3.109 |
| Natural Product Likeliness | 1.15 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.834 |
| Pgp-sub | 0.009 |
| HIA | 0.003 |
| CACO-2 | -4.583 |
| MDCK | 0.0000229 |
| BBB | 0.401 |
| PPB | 0.968863 |
| VDSS | 4.333 |
| FU | 0.0339354 |
| CYP1A2-inh | 0.875 |
| CYP1A2-sub | 0.812 |
| CYP2c19-inh | 0.627 |
| CYP2c19-sub | 0.908 |
| CYP2c9-inh | 0.324 |
| CYP2c9-sub | 0.608 |
| CYP2d6-inh | 0.404 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.348 |
| CYP3a4-sub | 0.578 |
| CL | 9.906 |
| T12 | 0.161 |
| hERG | 0.026 |
| Ames | 0.009 |
| ROA | 0.061 |
| SkinSen | 0.94 |
| Carcinogencity | 0.163 |
| EI | 0.981 |
| Respiratory | 0.62 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.602816 |